Comparative efficacy and safety of CAR T-cell therapy versus standard of care for relapsed/refractory diffuse large B-cell lymphoma: A meta-analysis.

Authors: Nneoma Ubah, Suchith Boodgere Suresh, Muhammad Hisham Wazir, Chidiebube Ugwu, Eugene Annor, Gogo Ibodeng, Anup Kasi

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e14526

Source: Full article


Abstract

e14526